Supplementary Figure 1 from Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation Article Swipe

View

Danny Rischin , David C. Bibby , Geoff Chong , Gabriel Kremmidiotis , Annabell F. Leske , Clayton A. Matthews , Shirley Wong , Mark Rosen , Jayesh Desai ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.22442747.v1

PDF file - 191K

Related Topics

Concepts

Pharmacodynamics Pharmacokinetics Clinical trial Pharmacology Medicine Cancer research Internal medicine Oncology

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.22442747.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4362427352

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4362427352

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.22442747.v1

Digital Object Identifier
Title: Supplementary Figure 1 from Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Danny Rischin, David C. Bibby, Geoff Chong, Gabriel Kremmidiotis, Annabell F. Leske, Clayton A. Matthews, Shirley Wong, Mark Rosen, Jayesh Desai

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.22442747.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1078-0432.22442747.v1

Direct OA link when available
Concepts: Pharmacodynamics, Pharmacokinetics, Clinical trial, Pharmacology, Medicine, Cancer research, Internal medicine, Oncology

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4362427352
doi	https://doi.org/10.1158/1078-0432.22442747.v1
ids.doi	https://doi.org/10.1158/1078-0432.22442747.v1
ids.openalex	https://openalex.org/W4362427352
fwci
type	preprint
title	Supplementary Figure 1 from Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T13265
topics[0].field.id	https://openalex.org/fields/16
topics[0].field.display_name	Chemistry
topics[0].score	0.9747999906539917
topics[0].domain.id	https://openalex.org/domains/3
topics[0].domain.display_name	Physical Sciences
topics[0].subfield.id	https://openalex.org/subfields/1605
topics[0].subfield.display_name	Organic Chemistry
topics[0].display_name	Synthesis of Tetrazole Derivatives
topics[1].id	https://openalex.org/T11752
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.97079998254776
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2730
topics[1].subfield.display_name	Oncology
topics[1].display_name	Cancer Treatment and Pharmacology
topics[2].id	https://openalex.org/T11395
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9581999778747559
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2741
topics[2].subfield.display_name	Radiology, Nuclear Medicine and Imaging
topics[2].display_name	Radiopharmaceutical Chemistry and Applications
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C111113717
concepts[0].level	3
concepts[0].score	0.674088180065155
concepts[0].wikidata	https://www.wikidata.org/wiki/Q725307
concepts[0].display_name	Pharmacodynamics
concepts[1].id	https://openalex.org/C112705442
concepts[1].level	2
concepts[1].score	0.5238428115844727
concepts[1].wikidata	https://www.wikidata.org/wiki/Q323936
concepts[1].display_name	Pharmacokinetics
concepts[2].id	https://openalex.org/C535046627
concepts[2].level	2
concepts[2].score	0.46595484018325806
concepts[2].wikidata	https://www.wikidata.org/wiki/Q30612
concepts[2].display_name	Clinical trial
concepts[3].id	https://openalex.org/C98274493
concepts[3].level	1
concepts[3].score	0.435394823551178
concepts[3].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[3].display_name	Pharmacology
concepts[4].id	https://openalex.org/C71924100
concepts[4].level	0
concepts[4].score	0.39370983839035034
concepts[4].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[4].display_name	Medicine
concepts[5].id	https://openalex.org/C502942594
concepts[5].level	1
concepts[5].score	0.37473392486572266
concepts[5].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[5].display_name	Cancer research
concepts[6].id	https://openalex.org/C126322002
concepts[6].level	1
concepts[6].score	0.3692915439605713
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[6].display_name	Internal medicine
concepts[7].id	https://openalex.org/C143998085
concepts[7].level	1
concepts[7].score	0.3366962671279907
concepts[7].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[7].display_name	Oncology
keywords[0].id	https://openalex.org/keywords/pharmacodynamics
keywords[0].score	0.674088180065155
keywords[0].display_name	Pharmacodynamics
keywords[1].id	https://openalex.org/keywords/pharmacokinetics
keywords[1].score	0.5238428115844727
keywords[1].display_name	Pharmacokinetics
keywords[2].id	https://openalex.org/keywords/clinical-trial
keywords[2].score	0.46595484018325806
keywords[2].display_name	Clinical trial
keywords[3].id	https://openalex.org/keywords/pharmacology
keywords[3].score	0.435394823551178
keywords[3].display_name	Pharmacology
keywords[4].id	https://openalex.org/keywords/medicine
keywords[4].score	0.39370983839035034
keywords[4].display_name	Medicine
keywords[5].id	https://openalex.org/keywords/cancer-research
keywords[5].score	0.37473392486572266
keywords[5].display_name	Cancer research
keywords[6].id	https://openalex.org/keywords/internal-medicine
keywords[6].score	0.3692915439605713
keywords[6].display_name	Internal medicine
keywords[7].id	https://openalex.org/keywords/oncology
keywords[7].score	0.3366962671279907
keywords[7].display_name	Oncology
language	en
locations[0].id	doi:10.1158/1078-0432.22442747.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.22442747.v1
locations[1].id	pmh:oai:figshare.com:article/22442747
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Clinical_Pharmacodynamic_and_Pharmacokinetic_Evaluation_of_BNC105P_A_Phase_I_Trial_of_a_Novel_Vascular_Disrupting_Agent_and_Inhibitor_of_Cancer_Cell_Proliferation/22442747
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5060469120
authorships[0].author.orcid	https://orcid.org/0000-0002-3368-0386
authorships[0].author.display_name	Danny Rischin
authorships[0].author_position	first
authorships[0].raw_author_name	Danny Rischin
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5102731529
authorships[1].author.orcid	https://orcid.org/0000-0002-4123-6007
authorships[1].author.display_name	David C. Bibby
authorships[1].author_position	middle
authorships[1].raw_author_name	David C. Bibby
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5071685146
authorships[2].author.orcid
authorships[2].author.display_name	Geoff Chong
authorships[2].author_position	middle
authorships[2].raw_author_name	Geoff Chong
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5075832839
authorships[3].author.orcid
authorships[3].author.display_name	Gabriel Kremmidiotis
authorships[3].author_position	middle
authorships[3].raw_author_name	Gabriel Kremmidiotis
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5011262525
authorships[4].author.orcid
authorships[4].author.display_name	Annabell F. Leske
authorships[4].author_position	middle
authorships[4].raw_author_name	Annabell F. Leske
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5091488204
authorships[5].author.orcid
authorships[5].author.display_name	Clayton A. Matthews
authorships[5].author_position	middle
authorships[5].raw_author_name	Clayton A. Matthews
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5011946923
authorships[6].author.orcid	https://orcid.org/0000-0003-3810-6495
authorships[6].author.display_name	Shirley Wong
authorships[6].author_position	middle
authorships[6].raw_author_name	Shirley S. Wong
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5111808513
authorships[7].author.orcid
authorships[7].author.display_name	Mark Rosen
authorships[7].author_position	middle
authorships[7].raw_author_name	Mark A. Rosen
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5078038970
authorships[8].author.orcid	https://orcid.org/0000-0003-4246-9344
authorships[8].author.display_name	Jayesh Desai
authorships[8].author_position	last
authorships[8].raw_author_name	Jayesh Desai
authorships[8].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1078-0432.22442747.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure 1 from Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T13265
primary_topic.field.id	https://openalex.org/fields/16
primary_topic.field.display_name	Chemistry
primary_topic.score	0.9747999906539917
primary_topic.domain.id	https://openalex.org/domains/3
primary_topic.domain.display_name	Physical Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1605
primary_topic.subfield.display_name	Organic Chemistry
primary_topic.display_name	Synthesis of Tetrazole Derivatives
related_works	https://openalex.org/W2352350815, https://openalex.org/W2991030316, https://openalex.org/W2908757458, https://openalex.org/W2887865523, https://openalex.org/W2112528869, https://openalex.org/W2189230703, https://openalex.org/W2114878163, https://openalex.org/W2012213756, https://openalex.org/W2254638634, https://openalex.org/W2369345461
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1078-0432.22442747.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.22442747.v1
primary_location.id	doi:10.1158/1078-0432.22442747.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.22442747.v1
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.-	2
abstract_inverted_index.file	1
abstract_inverted_index.<p>PDF	0
abstract_inverted_index.191K</p>	3
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	9
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5899999737739563
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.05535855
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False